A.L. Sarroff Fund, LLC bought $1.0M of PetVivo (PETV)
Executed Mar 13, disclosed Mar 13, the same day.
Over the 21 trading sessions from the disclosed entry session (Mar 13), the stock returned +0.6% (delay-adjusted); from the execution session (Mar 13), +0.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
A.L. Sarroff Fund, LLC (10% owner) filed 5 Form 4 reports as a reporting entity in the trailing twelve months (5 purchases, 0 sales, 2 filed past the two-business-day deadline), most often in PetVivo Holdings, Inc. (PETV). Across 5 priced purchase filings, the average 21-session return was +11.8% from execution and -8.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of PETV (as filed, as filed), executed Mar 13.
Healthcare · PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animal…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→as filed
Exec Jun 9
Filed Jun 11 · 4:08 PM ET PETVPURCHASE PetVivo Holdings, Inc. $100K
250,000 sh × $0.40
Exec May 22
Filed May 26 · 4:18 PM ET PETVPURCHASE PetVivo Holdings, Inc. $401K
561,168 sh across 2 lots
Exec Apr 9 2024
Filed Jan 16 · 4:38 PM ET † PETVPURCHASE PetVivo Holdings, Inc. $100K
111,112 sh × $0.90
Exec Dec 15 2023
Filed Jan 16 · 4:37 PM ET †